Le Lézard
Classified in: Health
Subjects: CHI, AVO, MAT

FDA's Proposal to Prohibit Menthol Cigarettes, Flavored Cigars Will Save Lives and Should Be Implemented Quickly; FDA Must Do More to Reverse Youth E-Cigarette Epidemic


WASHINGTON, Nov. 15, 2018 /PRNewswire/ -- The proposals by the FDA today to prohibit menthol cigarettes and flavored cigars have enormous potential to drive down tobacco use and the death and disease it causes in the United States. If adopted, these two proposals will have a greater impact in reducing tobacco use by youth and the African-American community than any regulatory measure ever undertaken by the federal government. However, the FDA must move as quickly as possible to propose, finalize and implement the necessary regulations. If the FDA does so, it will be truly historic action to stop the tobacco industry from using flavored products to target and addict children, African Americans and other groups. We commend Commissioner Scott Gottlieb and the FDA for their leadership in advancing these life-saving proposals.

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

The FDA's actions on electronic cigarettes are a step forward, but don't go far enough. The FDA deserves praise for focusing the nation's attention on the epidemic of youth e-cigarette use, and for beginning to attack the problem, but the FDA's plan does not go far enough at this time.  It stops short of banning the flavors that have made e-cigarettes so popular with kids. Menthol and mint flavors will remain widely available despite new data being released today that shows 51 percent of high school students who currently use e-cigarettes use menthol- or mint-flavored products. With these flavors still widely available, it is doubtful that this plan will stem the tide of youth e-cigarette use and it will be critical for the FDA to quickly supplement the steps announced today. In addition, the Juul device itself and other e-cigarettes that deliver exceptionally high levels of nicotine will continue to be sold in convenience stores and gas stations.

It is also a positive step that the FDA recognizes the importance of curtailing marketing to kids, but it is critical that the FDA exercise its authority to remove products that are marketed in ways that appeal to kids. In addition, the FDA should stop sales of all flavored e-cigarette products that have not been subject to public health review by the agency and enforce rules prohibiting the sale of new or changed products without prior FDA review. By enforcing this pre-market review requirement, the FDA can prevent manufacturers from continuing to introduce products that appeal to kids.

New Data Show Skyrocketing Youth E-Cigarette Use

New data being released today by the CDC and the FDA underscores that youth e-cigarette use has reached epidemic levels and that flavors are a critical factor ? including the menthol and mint flavors that the FDA will leave widely available. Key findings from the 2018 National Youth Tobacco Survey:

E-cigarette use poses serious risks to the health of young people. A 2016 Surgeon General's report concluded that youth use of nicotine in any form, including e-cigarettes, is unsafe, can cause addiction and can harm the developing adolescent brain. A January 2018 report by the National Academies of Sciences, Engineering and Medicine concluded, "There is substantial evidence that e-cigarette use increases risk of ever using combustible tobacco cigarettes among youth and young adults."

More Information on Menthol Cigarettes and Other Flavored Products

Comments to FDA by health groups supporting a prohibition on all flavored tobacco products, including menthol cigarettes and flavored e-cigarettes and cigars

Fact sheet on menthol cigarettes

Fact sheet: Flavored tobacco products attract kids

 

SOURCE Campaign for Tobacco-Free Kids


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: